bayesian regression analysis program pks system (Abbott Laboratories)
90
Structured Review
Abbott Laboratories
bayesian regression analysis program pks system
Bayesian Regression Analysis Program Pks System, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bayesian+analysis+program/bayesian+program+pks+system/pm12841936-52-16-22
Average 90 stars, based on 1 article reviews
Bayesian Regression Analysis Program Pks System, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bayesian+analysis+program/bayesian+program+pks+system/pm12841936-52-16-22
Average 90 stars, based on 1 article reviews
bayesian regression analysis program pks system - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
other:Article Title: Sunday, 8 July: Posters Article Snippet: Predictions of midazolam concentrations using a population pharmacokinetic software (PKS) in intensive care patients M. Bolon, O. Bastien, C. Flamens, S. Paulus, R. Boulieu, Universite Claude Bernard Lyon 1, HoÃpital Cardiologique, Lyon, France According to the wide variability in individual responses to midazolam, drug monitoring is necessary in intensive care patients.. The aim of the study was to assess the performance of a bayesian program (PKS System, Abbott) for predicting midazolam concentrations using a limited sampling method in intensive care patients.. The study involved 37 patients receiving midazolam during shortor long-term infusion. Article Title: Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients. Article Snippet: What is Known and Objective: Individualization of carbamazepine (CBZ) dosage regimen in patients with epilepsy based on based on therapeutic drug monitoring (TDM) followed by estimation of pharmacokinetic (PK) parameters can help in better control of epilepsy.. Our objective was to establish a population (POP) PK model of CBZ for Egyptian adult and pediatric patients with epilepsy.. Method: Single steady-state (SS) trough plasma concentrations of CBZ were available for 302 patients with epilepsy (55Æ6 men and 44Æ4 women) who were categorized as children (n = 118) and adults (n = 184) with mean age (years) ± SD of 10Æ6 ± 4Æ8 and 29Æ4 ± 9Æ9, respectively. Article Title: Bayesian estimation of six different sets of carbamazepine pharmacokinetic parameters in Egyptian adult epileptic patients. Article Snippet: The individualization of carbamazepine (CBZ) dosage regimen based on estimation of pharmacokinetic (PK) parameters and measurement of serum drug concentration in epileptic patients can help to control epilepsy.. In a retrospective study, the predictive performance of six different sets of CBZ PK parameters selected according to the literature was evaluated in 60 adult epileptic patients.. Patients were administered controlled release CBZ (dose range: 200–1200 mg day−1) as monotherapy and one steady state serum concentration of the drug was available for each patient. Concentration Assay:Article Title: Evaluation of the estimation of midazolam concentrations and pharmacokinetic parameters in intensive care patients using a bayesian pharmacokinetic software (PKS) according to sparse sampling approach. Article Snippet: The aim of the study was to assess the performance of a bayesian program (PKS System, Abbott) for predicting midazolam concentrations and pharmacokinetic parameters in intensive care patients by comparing the pharmacokinetic parameters estimated by PKS to those calculated according to rich data.. The study involved 42 patients receiving midazolam infusion for two hours or for several days.. The program was used to predict plasma midazolam concentrations after feedback of 1, 2 or 3 concentrations. |